StockData
MAIA Biotechnology, Inc. logo

MAIA Biotechnology, Inc. (MAIA) stock

MAIANYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 5/30
$1.30+0.05 (+4.00%)

Close on Nov 18, 2026Market cap $79.07MP/E –Yield –

MAIA Biotechnology operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

MAIA Biotechnology's operating income for the twelve months ending Jun 30, 2026 was -$28.95M. For fiscal 2025 it was -$24.27M. The highest annual figure on record is -$7.79M in fiscal 2021.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$24.27M–
FY2024Dec 31, 2024-$16.96M–
FY2023Dec 31, 2023-$20.18M–
FY2022Dec 31, 2022-$16.18M–
FY2021Dec 31, 2021-$7.79M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$8.32M–
Q1 FY2026Mar 31, 2026-$6.95M–
Q4 FY2025Dec 31, 2025-$4.32M–
Q3 FY2025Sep 30, 2025-$9.36M–
Q2 FY2025Jun 30, 2025-$5.17M–
Q1 FY2025Mar 31, 2025-$5.43M–
Q4 FY2024Dec 31, 2024-$5.00M–
Q3 FY2024Sep 30, 2024-$4.19M–
Q2 FY2024Jun 30, 2024-$3.82M–
Q1 FY2024Mar 31, 2024-$3.95M–
Q4 FY2023Dec 31, 2023-$6.38M–
Q3 FY2023Sep 30, 2023-$4.96M–
Q2 FY2023Jun 30, 2023-$4.66M–
Q1 FY2023Mar 31, 2023-$4.18M–
Q4 FY2022Dec 31, 2022-$4.20M–
Q3 FY2022Sep 30, 2022-$5.10M–
Q2 FY2022Jun 30, 2022-$3.44M–
Q1 FY2022Mar 31, 2022-$3.44M–
Q4 FY2021Dec 31, 2021-$3.00M–
Q3 FY2021Sep 30, 2021-$2.23M–

More MAIA Biotechnology figures

See a number that looks wrong?